News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,567 Results
Type
Article (41560)
Company Profile (231)
Press Release (692764)
Multimedia
Podcasts (97)
Webinars (21)
Section
Business (204933)
Career Advice (2036)
Deals (35632)
Drug Delivery (134)
Drug Development (81614)
Employer Resources (173)
FDA (16551)
Job Trends (15002)
News (347038)
Policy (32758)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2608)
Accelerated approval (55)
ADA (44)
Adcomms (29)
Allergies (192)
Alliances (49582)
ALS (226)
Alzheimer's disease (1842)
Antibody-drug conjugate (ADC) (520)
Approvals (17036)
Artificial intelligence (727)
ASCO (327)
Autoimmune disease (347)
Automation (63)
Bankruptcy (364)
Best Places to Work (11635)
BIO (67)
BIOSECURE Act (20)
Biosimilars (235)
Biotechnology (149)
Bladder cancer (204)
Brain cancer (75)
Breast cancer (803)
Cancer (6320)
Cardiovascular disease (505)
Career advice (1733)
Career pathing (45)
CAR-T (355)
CDC (58)
Celiac Disease (3)
Cell therapy (965)
Cervical cancer (56)
Clinical research (71568)
Collaboration (2207)
Commercialization (1)
Company closure (5)
Compensation (1501)
Complete response letters (85)
COVID-19 (2754)
CRISPR (116)
C-suite (1244)
Cystic fibrosis (157)
Data (8660)
Decentralized trials (3)
Denatured (29)
Depression (174)
Dermatology (98)
Diabetes (667)
Diagnostics (7028)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (362)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (306)
Earnings (92233)
Editorial (68)
Employer branding (21)
Employer resources (155)
Events (120621)
Executive appointments (1132)
FDA (20590)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1856)
Gene editing (246)
Generative AI (62)
Gene therapy (750)
GLP-1 (1093)
Government (4752)
Grass and pollen (6)
Guidances (421)
Healthcare (19146)
Hematology (192)
HIV (90)
Huntington's disease (62)
IgA nephropathy (113)
Immunology and inflammation (302)
Immuno-oncology (106)
Indications (222)
Infectious disease (3120)
Inflammatory bowel disease (222)
Inflation Reduction Act (14)
Influenza (142)
Intellectual property (320)
Interviews (321)
IPO (16680)
IRA (50)
Job creations (3650)
Job search strategy (1432)
JPM (58)
Kidney cancer (21)
Labor market (112)
Layoffs (576)
Leadership (42)
Legal (7954)
Liver cancer (103)
Longevity (35)
Lung cancer (836)
Lymphoma (477)
Machine learning (65)
Management (61)
Manufacturing (1159)
Marketing (4)
MASH (208)
Medical affairs (1)
Medical device (13997)
Medtech (14170)
Mergers & acquisitions (20272)
Metabolic disorders (1649)
mRNA (230)
Multiple sclerosis (200)
NASH (17)
Neurodegenerative disease (459)
Neuropsychiatric disorders (109)
Neuroscience (3478)
Neurotech (1)
NextGen: Class of 2026 (6524)
Non-profit (4539)
Now hiring (83)
Obesity (758)
Opinion (297)
Ovarian cancer (241)
Pain (266)
Pancreatic cancer (354)
Parkinson's disease (394)
Partnered (36)
Patents (643)
Patient recruitment (772)
Peanut (67)
People (59924)
Pharmaceutical (54)
Pharmacy benefit managers (33)
Phase 1 (22316)
Phase 2 (31534)
Phase 3 (23459)
Pipeline (9887)
Policy (331)
Postmarket research (2569)
Preclinical (9478)
Press Release (64)
Prostate cancer (335)
Psychedelics (57)
Radiopharmaceuticals (345)
Rare diseases (1184)
Real estate (5973)
Recruiting (71)
Regulatory (25846)
Reports (56)
Research institute (2423)
Resumes & cover letters (354)
Rett syndrome (46)
RNA editing (25)
RSV (90)
Schizophrenia (182)
Series A (315)
Series B (233)
Service/supplier (11)
Sickle cell disease (121)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (48)
Startups (3649)
State (2)
Stomach cancer (18)
Supply chain (134)
Tariffs (87)
The Weekly (66)
Vaccines (1151)
Venture capital (121)
Weight loss (483)
Women's health (138)
Worklife (21)
Date
Today (92)
Last 7 days (496)
Last 30 days (2320)
Last 365 days (30377)
2026 (16363)
2025 (30166)
2024 (35176)
2023 (40072)
2022 (51173)
2021 (55706)
2020 (54080)
2019 (46535)
2018 (35015)
2017 (32106)
2016 (31479)
2015 (37551)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (742)
Alabama (93)
Alaska (7)
Arizona (367)
Arkansas (14)
Asia (39951)
Australia (6549)
California (14026)
Canada (3972)
China (1495)
Colorado (598)
Connecticut (613)
Delaware (434)
Europe (86483)
Florida (2117)
Georgia (447)
Hawaii (3)
Idaho (63)
Illinois (1154)
India (99)
Indiana (633)
Iowa (25)
Japan (601)
Kansas (134)
Kentucky (51)
Louisiana (58)
Maine (76)
Maryland (1665)
Massachusetts (10051)
Michigan (377)
Minnesota (758)
Mississippi (6)
Missouri (149)
Montana (33)
Nebraska (30)
Nevada (150)
New Hampshire (84)
New Jersey (3673)
New Mexico (30)
New York (3688)
North Carolina (1766)
North Dakota (9)
Northern California (7093)
Ohio (420)
Oklahoma (23)
Oregon (41)
Pennsylvania (2790)
Puerto Rico (31)
Rhode Island (52)
South America (1113)
South Carolina (87)
South Dakota (2)
Southern California (5564)
Tennessee (231)
Texas (2251)
United States (49474)
Utah (417)
Vermont (2)
Virginia (344)
Washington D.C. (81)
Washington State (1115)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
734,567 Results for "avirmax inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avirmax Biopharma Inc. Proudly Presents at the 2026 ARVO Annual Meeting in Denver, Colorado
April 28, 2026
·
1 min read
Biotech Bay
Avirmax Inc. to Make Scientific Presentations at ASGCT in Baltimore
Avirmax Inc., will make two scientific presentations at the upcoming American Society of Gene and Cell Therapy (ASGCT) annual meeting in Baltimore between May 7th and 11th, 2024.
April 16, 2024
·
2 min read
Press Releases
Avirmax Biopharma Inc. to Present at the 2025 ARVO Annual Meeting in Salt Lake City
April 23, 2025
·
2 min read
Biotech Bay
Avirmax Biopharma Inc. to Present at the 2024 ARVO Annual Meeting in Seattle
Avirmax Biopharma Inc., will make three scientific presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Seattle between May 5th and 9th, 2024.
April 1, 2024
·
2 min read
Drug Development
Avirmax Biopharma Inc. Receives IND Approval for Phase I/IIa Trial to Treat Wet AMD including PCV
Avirmax Biopharma, Inc. is pleased to announce that it has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to initiate a Phase I/IIa clinical trial for its gene therapy treatment targeting wet Age-related Macular Degeneration.
May 30, 2024
·
2 min read
Biotech Bay
Avirmax Inc. Will Attend the BioProcess International Meeting in Boston
Avirmax Inc., Vice President of Research, Dr. Li Ou, and Associate Director of Operations, Ms. June Song , will attend the BioProcess International meeting in Boston between September 18th to 21st , 2023.
September 13, 2023
·
2 min read
Press Releases
Avirmax Inc. to Present at the ARVO Frontiers in Ocular Gene Therapy Research Conference
November 12, 2024
·
2 min read
Press Releases
Avirmax Biopharma Announces Completion of the First Cohort of Patient Enrollment in Clinical Trial of ABI-110, a Gene Therapy for Wet AMD Including PCV
February 3, 2025
·
2 min read
Press Releases
Avirmax Biopharma Inc. to Exhibit Development of Next Generation Gene Therapies for Ocular Diseases at the AAO 2024 Annual Meeting in Chicago
October 15, 2024
·
2 min read
Biotech Bay
Avirmax Biopharma Inc. Will Present at Glaucoma 360 New Horizons Forum 2023
Avirmax Biopharma Inc. (ABI), Chief Executive and Scientific Officer, Shengjiang Shawn Liu will present the Avirmax BioPharma Inc (ABI)'s progress in the innovation and development of genetic medicines for glaucoma treatment at Glaucoma 360 New Horizons Forum at The Westin St. Francis in San Francisco, Feb 03, 2023.
February 3, 2023
·
2 min read
1 of 73,457
Next
